Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor

Infect Dis Ther. 2024 Sep;13(9):2103. doi: 10.1007/s40121-024-01030-0.
No abstract available

Publication types

  • Published Erratum